Skip to main content
logo
Creo Medical Group PLC (AIM:CREO)
London flag London · Delayed Price · Currency is GBP · Price in GBX
13.99
+0.24 (1.78%)
Jul 28, 2026, 8:34 AM GMT

Creo Medical Group Income Statement

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
64427.225.16
Revenue Growth
50.00%0%-85.29%8.10%166.85%
Cost of Revenue
3.62.11.71413.58
Gross Profit
2.41.92.313.211.59
Selling, General & Admin
23.130.329.64441.54
Other Operating Expenses
-1.20.4-0.4-0.1-0.05
Total Operating Expenses
21.930.729.243.941.49
Operating Income
-17.8-28.8-26.9-30.7-29.91
Interest Income
2.30.20.70.10.03
Interest Expense
-0.3-0.4-0.2-0.3-0.46
Total Non-Operating Income (Expense)
2-0.20.5-0.2-0.43
Pretax Income
-17.5-29-26.4-30.9-30.34
Provision for Income Taxes
0-1.2-2.7-4-5.74
Net Income
-17.5-27.8-23.7-26.9-24.6
Earnings From Discontinued Operations
22.8-0.92--
Net Income to Common
-17.5-27.8-23.7-26.9-24.6
Net Income Growth
-----
Shares Outstanding (Basic)
412370313181164
Shares Outstanding (Diluted)
415370313181164
Shares Change
12.26%18.20%72.61%10.28%5.54%
EPS (Basic)
0.01-0.08-0.07-0.15-0.15
EPS (Diluted)
0.01-0.08-0.07-0.15-0.15
EPS Growth
-----

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-19.1-22.5-22.8-28.1-31.99
Free Cash Flow Growth
-----
Free Cash Flow Per Share
-0.05-0.06-0.07-0.15-0.19
Gross Margin
40.00%47.50%57.50%48.53%46.04%
Operating Margin
-296.67%-720.00%-672.50%-112.87%-118.86%
Profit Margin
-291.67%-695.00%-592.50%-98.90%-97.75%
FCF Margin
-318.33%-562.50%-570.00%-103.31%-127.13%
EBITDA
-16.8-26.3-23.5-27.6-27.35
EBITDA Margin
-280.00%-657.50%-587.50%-101.47%-108.68%
EBIT
-17.8-28.8-26.9-30.7-29.91
EBIT Margin
-296.67%-720.00%-672.50%-112.87%-118.86%
Effective Tax Rate
0.00%4.14%10.23%12.95%18.93%